反式-肉桂酰咪唑 | 1138-15-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 中文名称: 反式-肉桂酰咪唑
• 中文别名: N-反式-肉桂酸基咪唑；N--肉桂酸基咪唑
• 英文名称: cinnamoyl imidazole
• 英文别名: 1-cinnamoylimidazole；N-trans-Cinnamoylimidazole；(E)-1-imidazol-1-yl-3-phenylprop-2-en-1-one
• CAS: 1138-15-4
• 化学式: C₁₂H₁₀N₂O
• 分子量: 198.224
• InChiKey: XVGXMXZUJNAGFZ-VOTSOKGWSA-N

物化性质

• 熔点：
  127 °C
• 沸点：
  335.53°C (rough estimate)
• 密度：
  1.1447 (rough estimate)
• 稳定性/保质期：
  如果按照规格正确使用和储存，就不会发生分解，不存在已知的危险反应。请避免接触氧化物、水分/潮湿、热源以及酸性物质。

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  34.9
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• TSCA：
  Yes
• 危险品标志：
  Xn
• 危险类别码：
  R22
• 海关编码：
  2933290090
• 安全说明：
  S24/25
• 储存条件：
  请将贮藏器密封，并存放在阴凉干燥处。同时，确保工作环境具有良好的通风或排气设施。

SDS

Name:	N-trans-Cinnamoylimidazole 97% Material Safety Data Sheet
Synonym:
CAS:	1138-15-4

Section 1 - Chemical Product MSDS Name:N-trans-Cinnamoylimidazole 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
1138-15-4	N-trans-Cinnamoylimidazole	97%	214-510-8

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Light sensitive.Moisture sensitive.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam. Use agent most appropriate to extinguish fire. Do NOT get water inside containers.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation. Do not get water inside containers.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Store protected from light. Do not allow contact with water. Keep from contact with moist air and steam.
Storage:
Do not store in direct sunlight. Store in a tightly closed container. Keep refrigerated. (Store below 4C/39F.) Store protected from moisture. Store protected from light. Store under nitrogen.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1138-15-4: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: light yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 133-135 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C12H10N2O
Molecular Weight: 198.0828

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions. Moisture sensitive. Light sensitive.
Conditions to Avoid:
Incompatible materials, light, dust generation, exposure to moist air or water.
Incompatibilities with Other Materials:
Moisture, oxidizing agents, strong acids.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1138-15-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-trans-Cinnamoylimidazole - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1138-15-4: No information available.
Canada
CAS# 1138-15-4 is listed on Canada's NDSL List.
CAS# 1138-15-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1138-15-4 is listed on the TSCA inventory.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  反式-肉桂酰咪唑 在 La-(S)-BINOL-Ph₃AsO 、 4 A molecular sieve 作用下， 以 四氢呋喃 、 甲苯 为溶剂， 反应 4.0h， 生成 (2R,3S)-2,3-epoxy-N-methyl-3-phenylpropanamide
  参考文献：
  名称：

  镧系元素-BINOL配合物催化α，β-不饱和羧酸咪唑化物和酰胺的不对称环氧化

  摘要：

  研究了α，β-不饱和羧酸咪唑化物和简单酰胺的高度对映选择性催化不对称环氧化反应。在5-10 mol％的镧系元素-BINOL配合物的存在下，反应在高底物普遍性下可顺利进行。特别地，在α，β-不饱和酰胺的情况下，几乎具有完美的对映选择性（> 99％ee）。相应的环氧化物已成功转化为多种类型的有用手性化合物，例如α，β-环氧酯，α，β-环氧酰胺，α，β-环氧醛，α，β-环氧β-酮酸酯，α-和β-羟基羰基化合物。进行B3LYP密度泛函研究以预测底物反应性。

  DOI：

  10.1016/j.tet.2003.06.010
• 作为产物：
  描述：

  肉桂酸 、 N,N'-羰基二咪唑 以 二氯甲烷 为溶剂， 以93%的产率得到反式-肉桂酰咪唑
  参考文献：
  名称：

  实用的化学选择性酰化：氨基醇与 N-羰基咪唑的有机催化化学发散酯化和酰胺化

  摘要：

  化学选择性转化是高效有机合成的基石；然而，即使是简单的转化，如酰化反应，要实现这一目标也常常是一个挑战。我们报告说，N-羰基咪唑分别在吡啶鎓离子或 1,8-二氮杂双环 [5.4.0] undec-7-ene (DBU) 存在下能够催化化学发散的苯胺或醇酰化。两种酰化反应都显示出对目标基团的高而广泛的化学选择性。在 DBU 催化的酯化中观察到了前所未有的化学选择性水平：从含有伯苯胺、醇、苯酚、仲酰胺和N的分子中获得单一酯化产物-H吲哚基团。这些酰化反应非常实用，因为它们只涉及容易获得、便宜且相对安全的试剂；可以在多克规模上进行；并且可以通过原位形成酰基咪唑亲电试剂直接用于羧酸。

  DOI：

  10.1002/anie.202107438

文献信息

• An Environmentally Sustainable Mechanochemical Route to Hydroxamic Acid Derivatives
  作者：Rita Mocci、Lidia De Luca、Francesco Delogu、Andrea Porcheddu

  DOI：10.1002/adsc.201600350

  日期：2016.10.6

  An operationally simple, and cost efficient conversion of carboxylic acids into hydroxamic acid derivatives via a high‐energy mechanochemical activation is presented. This ball milling methodology was applied to a wide variety of carboxylic acids dramatically improving purification issues associated with this class of molecules, which still remain one of the main bottlenecks of classical methodologies

  提出了通过高能机械化学活化将羧酸简单，经济地转化为异羟肟酸衍生物的方法。该球磨方法论已应用于多种羧酸，大大改善了与此类分子相关的纯化问题，而这些问题仍然是经典方法学的主要瓶颈之一。
• The Michael Reaction of N-Cinnamoylazoles with Phenols. A Simple Synthesis of 4-Arylchroman-2-ones and 1-Arylbenzo[f]chroman-3-ones
  作者：Giovanna Speranza、Carlo F. Morelli、Paolo Manitto

  DOI：10.1055/s-2000-6233

  日期：——

  4-Arylchroman-2-ones 3 and 1-arylbenzo[f]chroman-3-ones 6 have been prepared in moderate to good yields by reaction of dihydric or trihydric phenols with p-substituted N-cinnamoylazoles in dichloromethane under reflux in the presence of DBU.

  4-芳基色满-2-酮3和1-芳基苯并[f]色满-3-酮6已通过将二羟基或三羟基苯酚与对位取代的N-肉桂酰基吡唑在二氯甲烷中回流并在DBU存在下反应，以中等至良好的产率制备。
• NOVEL ROCK INHIBITORS
  申请人：Leysen Dirk

  公开号：US20140057942A1

  公开（公告）日：2014-02-27

  The present invention relates to new kinase inhibitors of Formula (I), wherein X is oxygen, —NH—, or a direct bond; Y is —NH— or a direct bond; n is an integer from 0 to 4; m is an integer from 0 to 4; Cy represents a bivalent radical consisting of a satured (poly)cycle, including fused, bi-, spiro or bridged carbocycles and heterocycles; in particular selected from the group consisting of: Formula (II), Ar is selected from the group comprising: Formula (III), R 2 is hydrogen or methyl; R 8 is hydrogen, methyl, halogen, or alkynyl; R 1 is an aryl or heteroaryl more specifically ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In particular, the present invention relates to new ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In addition, the invention relates to methods of treatment and use of said compounds in the manufacture of a medicament for the application to a number of therapeutic indications including sexual dysfunction, inflammatory diseases, ophthalmic diseases and Respiratory diseases.

  本发明涉及新型激酶抑制剂，其化学式为(I)，其中X是氧、—NH—或直接键；Y是—NH—或直接键；n是从0到4的整数；m是从0到4的整数；Cy代表由饱和（多）环组成的二价基团，包括融合的、双的、螺环或桥接的碳环和杂环；特别是从以下组中选择：化学式（II），Ar是从包括化学式（III）的组中选择；R2是氢或甲基；R8是氢、甲基、卤素或炔基；R1是芳基或杂芳基，更具体地是ROCK抑制剂，包含此类抑制剂的组合物，特别是药品，以及此类抑制剂在治疗和预防疾病中的用途。特别是，本发明涉及新型ROCK抑制剂，包含此类抑制剂的组合物，特别是药品，以及此类抑制剂在治疗和预防疾病中的用途。此外，本发明还涉及治疗方法以及使用所述化合物在制造药品中的应用，用于治疗包括性功能障碍、炎症性疾病、眼科疾病和呼吸系统疾病等多种治疗适应症。
• [EN] NOVEL ROCK INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS DE ROCK
  申请人：AMAKEM NV

  公开号：WO2014068035A1

  公开（公告）日：2014-05-08

  The present invention relates to new kinase inhibitors, more specifically ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In particular, the present invention relates to new ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In addition, the invention relates to methods of treatment and use of said compounds in the manufacture of a medicament for the application to a number of therapeutic indications including sexual dysfunction, inflammatory diseases, ophthalmic diseases and Respiratory diseases. Compounds of the invention display soft drug characteristics, i.e. they are rapidly inactivated upon entry in the systemic circulation. Therefore, they allow for reduced systemic exposure to functionally active ROCK inhibitors.

  本发明涉及新型激酶抑制剂，更具体地说是ROCK抑制剂，包括含有此类抑制剂的组合物，尤其是药物，以及此类抑制剂在治疗和预防疾病中的用途。特别是，本发明涉及新型ROCK抑制剂，包括含有此类抑制剂的组合物，尤其是药物，以及此类抑制剂在治疗和预防疾病中的用途。此外，本发明还涉及治疗方法和使用所述化合物在制造药剂中的应用，用于治疗包括性功能障碍、炎症性疾病、眼科疾病和呼吸系统疾病等多种治疗适应症。本发明的化合物表现出软药特性，即它们在进入系统循环后迅速失活。因此，它们允许减少对功能活性ROCK抑制剂的系统性暴露。
• Organometallic-type reactions in aqueous media mediated by indium. Allylation of acyloyl-imidazoles and pyrazoles. Regioselective synthesis of β,γ-unsaturated ketones
  作者：Vernal J. Bryan、Tak-Hang Chan

  DOI：10.1016/s0040-4039(97)01512-8

  日期：1997.9

  Indium mediated coupling of allylic bromide with acyloyl-imidazoles or pyrazoles in aqueous media gives the corresponding tertiary alcohols or ketones in good yield. The reaction provides a facile regioselective synthesis of β,γ-unsaturated ketones and its usefulness is demonstrated by the synthesis of the monoterpene artemesia ketone.

  在水性介质中，铟介导的烯丙基溴与酰基酰咪唑或吡唑的偶合以良好的收率得到相应的叔醇或酮。该反应提供了β，γ-不饱和酮的容易的区域选择性合成，并且其有效性由单萜蒿蒿酮的合成证明。

表征谱图